| 3.0 |
9.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 1.9 |
5.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.7 |
5.2 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.2 |
6.1 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.1 |
12.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.1 |
3.3 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 1.0 |
6.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.9 |
4.3 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) progesterone secretion(GO:0042701) negative regulation of hair follicle development(GO:0051799) positive regulation of ovulation(GO:0060279) |
| 0.8 |
2.5 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.8 |
4.0 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.8 |
7.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.7 |
7.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.7 |
3.7 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.7 |
4.3 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.7 |
9.3 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.7 |
3.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.7 |
3.9 |
GO:0046103 |
ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
| 0.6 |
1.9 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.6 |
4.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.6 |
1.7 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.5 |
1.6 |
GO:0010752 |
signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.5 |
3.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.5 |
2.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.5 |
3.9 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.5 |
1.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.4 |
2.1 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.4 |
2.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 |
1.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.4 |
2.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.4 |
1.1 |
GO:0048819 |
positive regulation of hair follicle maturation(GO:0048818) regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.4 |
1.1 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.3 |
5.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.3 |
1.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.3 |
1.8 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.3 |
2.0 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 |
1.6 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.3 |
1.4 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.3 |
2.1 |
GO:2000809 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.3 |
0.8 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.3 |
1.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
1.2 |
GO:0046684 |
response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.2 |
1.5 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
3.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.2 |
2.6 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
2.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 |
2.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
0.2 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.2 |
0.6 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.2 |
7.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.2 |
4.1 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 |
1.7 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
2.0 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) cellular response to magnesium ion(GO:0071286) regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
3.7 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.2 |
0.8 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.3 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.1 |
0.8 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
0.4 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.1 |
1.0 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
1.5 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.4 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.1 |
1.3 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.8 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.5 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
1.8 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
3.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.5 |
GO:0032511 |
regulation of multivesicular body size(GO:0010796) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
2.0 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
3.2 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
1.9 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
3.7 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.6 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
1.0 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
3.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.5 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.6 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
1.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
1.1 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.3 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.7 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
1.2 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 |
1.3 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
0.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
3.2 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
4.6 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
7.2 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
3.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.2 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) cellular response to potassium ion starvation(GO:0051365) |
| 0.0 |
5.3 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
0.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
4.0 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.4 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
2.6 |
GO:0007613 |
memory(GO:0007613) |
| 0.0 |
0.8 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 |
0.4 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.8 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 |
2.9 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 |
0.8 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
1.0 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.7 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.6 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
2.0 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
0.7 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 |
0.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 |
0.9 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
2.3 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.5 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.3 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.0 |
7.2 |
GO:0016337 |
single organismal cell-cell adhesion(GO:0016337) |
| 0.0 |
1.4 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.2 |
GO:0043122 |
regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
